Form4.ai tracks every SEC insider trade in real time. See every ALLO insider filing with a free account — no card.
See every ALLO insider filing — free account, no card.
Free accountAllogene Therapeutics, Inc. (ALLO) has 2 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $112K. Most recent filing: Oct. 23, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 23, 2026 SEC filing | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sold | $48,698 | — |
| Aug 25, 2026 SEC filing | Douglas Earl Martin SVP, General Counsel | Sold | $62,958 | — |
Create a free account to see all 2 ALLO filings from the last 90 days. No card needed.
Create free accountWant ALLO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.